Fibroadenoma

Breast fibroadenoma is the most common benign breast  tumor. 10% of women will develop a fibroadenoma at some point in their lifetime.

In the United States,  fibroadenomas account for around  half of the 1.6 million breast biopsies performed each year.

In France, several tens of thousands of fibroadenomas are detected each year. This pathology can be observed at any age but mainly concerns women under 30. The fibroadenoma is generally detected by palpation. However, the fibroadenoma can be  asymptomatic and may  only be detected after a mammography or an ultrasound examination.  Detection of a nodule  in the breast will prompt  cytopuncture  or a microbiopsy. If the analysis reveals a fibroadenoma, the physician and the patient will decide on the best course of action: regular monitoring or (if the fibroadenoma is bothersome, growing in size or causing anxiety) ablation. The benign nature of the fibroadenoma means that both the patient and physician may consider that surgery is not an appropriate option. The HIFU may be a well-matched response to this problem.

For more information about Theraclion’s answer to breast fibroadenomas, please click-here.